Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
21.59
-0.30 (-1.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Stevanato Group Revenue
In the year 2024, Stevanato Group had annual revenue of 1.10B EUR with 1.72% growth. Stevanato Group had revenue of 330.60M in the quarter ending December 31, 2024, with 3.11% growth.
Revenue (ttm)
1.10B EUR
Revenue Growth
+1.72%
P/S Ratio
5.12
Revenue / Employee
199,970 EUR
Employees
5,521
Market Cap
5.89B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.10B | 18.68M | 1.72% |
| Dec 31, 2023 | 1.09B | 101.67M | 10.34% |
| Dec 31, 2022 | 983.68M | 139.76M | 16.56% |
| Dec 31, 2021 | 843.92M | 181.88M | 27.47% |
| Dec 31, 2020 | 662.04M | 125.50M | 23.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
STVN News
- 3 days ago - Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 6 weeks ago - Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum - Business Wire
- 7 weeks ago - Stevanato: Ramping Syringe Demand, Buy Confirmed - Seeking Alpha
- 7 weeks ago - Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024 - Business Wire
- 2 months ago - Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025 - Business Wire
- 3 months ago - Stevanato Group to Present at Upcoming Investor Conference - Business Wire
- 5 months ago - Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha